P3 Health Partners (PIII) Stock Price, News & Analysis

Company Overview

P3 Health Partners Inc. is a physician-led healthcare organization focused on value-based care for older adults, particularly beneficiaries enrolled in Medicare Advantage plans. The company works with primary care physicians, health plans and other healthcare providers to coordinate services and improve patient outcomes while managing the overall cost of care.

P3 supports its network through primary care services, care coordination, clinical programs and technology-enabled population health management. Its interdisciplinary care teams help patients manage chronic conditions, navigate the healthcare system and access services such as preventive care, behavioral health support and specialty care. The company also provides administrative, clinical and operational support to affiliated physicians participating in value-based contracts.

P3 Health Partners was established to expand physician-led, patient-centered care models and became a publicly traded company in 2021 through a business combination with Foresight Acquisition Corp. III. The organization has served Medicare Advantage populations in markets including Nevada, Arizona and California. Its operations and leadership have evolved as the company has focused on strengthening its provider network and value-based healthcare platform.

Key Stats

• Today's Range: $4.02 to $4.72
• 50-Day Range: $4.03 to $12.83
• 52-Week Range: $1.52 to $16.89
• Volume: 42,109 shs
• Average Volume: 444,779 shs
• Market Capitalization: $31.73 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $17.00
• Consensus Rating: Hold

P3 Health Partners Stock Analysis - MarketRank™

P3 Health Partners scored higher than 61% of companies evaluated by MarketBeat, and ranked 402nd out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

P3 Health Partners has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 1 sell rating.

Upside Potential

P3 Health Partners has a consensus price target of $17.00, representing about 289.0% upside from its current price of $4.37.

Amount of Analyst Coverage

P3 Health Partners has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of P3 Health Partners is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of P3 Health Partners is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.21% of the float of P3 Health Partners has been sold short.

Short Interest Ratio / Days to Cover

P3 Health Partners has a short interest ratio ("days to cover") of 1.35, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in P3 Health Partners has recently decreased by 50.41%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

P3 Health Partners does not currently pay a dividend.

Dividend Growth

P3 Health Partners does not have a long track record of dividend growth.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.93

News Sentiment

P3 Health Partners has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for P3 Health Partners this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, P3 Health Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $824,000.00 in company stock.

Percentage Held by Insiders

10.86% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

7.75% of the stock of P3 Health Partners is held by institutions.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 10/14/2026
• The ThinkEquity Conference: 10/15/2026
• Next Earnings (Estimated): 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:PIII
• CIK: 1832511
• Web: www.p3hp.org
• Phone: (312) 822-8897
• Fax: N/A
• Employees: 320
• Year Founded: N/A

Price Target and Rating

• Average Price Target for P3 Health Partners: $17.00
• High Price Target: $23.00
• Low Price Target: $14.00
• Potential Upside/Downside: +289.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($33.00)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$147.95 million
• Net Margins: -6.55%
• Pretax Margin: -15.12%
• Return on Equity: N/A
• Return on Assets: -16.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.46
• Quick Ratio: 0.46

Sales & Book Value

• Annual Sales: $1.46 billion
• Price / Sales: 0.02
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($21.55) per share
• Price / Book: -0.20

Miscellaneous

• Outstanding Shares: 7,260,000
• Free Float: 6,472,000
• Market Cap: $31.73 million
• Optionable: Not Optionable
• Beta: 1.70